[HTML][HTML] GSK-3 as potential target for therapeutic intervention in cancer

JA McCubrey, LS Steelman, FE Bertrand, NM Davis… - Oncotarget, 2014 - ncbi.nlm.nih.gov
The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified and
studied in the regulation of glycogen synthesis. GSK-3 functions in a wide range of cellular …

[HTML][HTML] Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance

JA McCubrey, LS Steelman, WH Chappell… - Oncotarget, 2012 - ncbi.nlm.nih.gov
Abstract The Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades are often activated by
genetic alterations in upstream signaling molecules such as receptor tyrosine kinases …

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

I Landa, T Ibrahimpasic, L Boucai… - The Journal of …, 2016 - Am Soc Clin Investig
BACKGROUND. Poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer
(ATC) are rare and frequently lethal tumors that so far have not been subjected to …

Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies

I Landa, N Pozdeyev, C Korch, LA Marlow… - Clinical Cancer …, 2019 - AACR
Purpose: Thyroid cancer cell lines are valuable models but have been neglected in
pancancer genomic studies. Moreover, their misidentification has been a significant …

Genomic alterations in thyroid cancer: biological and clinical insights

I Landa, ME Cabanillas - Nature Reviews Endocrinology, 2024 - nature.com
Tumours can arise from thyroid follicular cells if they acquire driver mutations that
constitutively activate the MAPK signalling pathway. In addition, a limited set of additional …

p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer

DG McFadden, A Vernon… - Proceedings of the …, 2014 - National Acad Sciences
Anaplastic thyroid carcinoma (ATC) has among the worst prognoses of any solid
malignancy. The low incidence of the disease has in part precluded systematic clinical trials …

The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions

TGP Grunewald, H Bach, A Cossarizza… - Biology of the …, 2012 - Wiley Online Library
The human six‐transmembrane epithelial antigen of the prostate (STEAP) protein family
contains at least five homologous members. The necessity of multiple homologous STEAP …

Mechanistic insights of thyroid cancer progression

LJ Leandro-García, I Landa - Endocrinology, 2023 - academic.oup.com
Differentiated thyroid cancers (DTCs) are primarily initiated by mutations that activate the
MAPK signaling cascade, typically at BRAF or RAS oncoproteins. DTCs can evolve to more …

Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases

B Bonhomme, Y Godbert, G Perot, A Al Ghuzlan… - Thyroid, 2017 - liebertpub.com
Background: Anaplastic thyroid carcinoma (ATC) is a rare tumor, with poorly defined
oncogenic molecular mechanisms and limited therapeutic options contributing to its poor …

Activating BRAF and PIK3CA mutations cooperate to promote anaplastic thyroid carcinogenesis

RP Charles, J Silva, G Iezza, WA Phillips… - Molecular Cancer …, 2014 - AACR
Thyroid malignancies are the most common type of endocrine tumors. Of the various
histologic subtypes, anaplastic thyroid carcinoma (ATC) represents a subset of all cases but …